Allakos (ALLK) will discontinue further development of AK006
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- S&P 500 and Nasdaq end higher on cool inflation data, solid bank earnings
- IBM plunges 19% as memory capex squeeze derails Q2 earnings
- Fed’s Warsh says central bank won’t tolerate high inflation
- Software stocks tumble: High memory prices cannibalize enterprise tech capex
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
- IBM misses Q2 targets as mainframe and software sales disappoint
- Verizon planning new round of layoffs this week - Barron’s
- Goldman Sachs Upgrades NIO (NIO) to Buy
- BofA Securities on AppLovin: 'Current valuation appears reasonable'
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
Allakos Inc. (ALLK) PT Lowered to $0.40 at Jefferies
January 27, 2025 12:56 PM ESTJefferies analyst Kevin Strang lowered the price target on Allakos Inc. (NASDAQ: ALLK) to $0.40 (from $1.40) while maintaining a Hold rating.
The analyst comments "We didn't have high conviction heading into the event, as there was no clin evidence of mast cell inhibition... More
